<?xml version="1.0" encoding="UTF-8"?>
<p id="Par5">At this time, it appears that all subjects who have recovered from COVID-19 have developed T cells that recognize specific viral epitopes, including the S protein
 <sup>
  <xref ref-type="bibr" rid="CR12">12</xref>
 </sup>. The extraordinarily wide range of symptoms and severity, including many infected subjects showing mild or no effects, may be due to cross-reactivity of T cells previously developed in response to prior coronavirus infections that cross-react with SARS-CoV-2, and it is remarkable that nearly half of individuals tested from blood samples prior to 2019 have such cells
 <sup>
  <xref ref-type="bibr" rid="CR12">12</xref>
 </sup>. It is also possible that different routes of infection, including via the gastrointestinal tract, may result in different symptoms
 <sup>
  <xref ref-type="bibr" rid="CR13">13</xref>
 </sup>.
</p>
